Search research articles
Contact Us
Filters
Showing results (1-10 of 15) with videos related to
Page
of 2
Sort By:
The New England Journal of Medicine
|
March 12, 2010
Stem-cell transplantation for sickle cell disease
Alexander Dew, Koen van Besien
Best Practice & Research. Clinical Haematology
|
March 7, 2020
The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!
Dickran Kazandjian, Alexander Dew, Elizabeth Hill
British Journal of Haematology
|
September 23, 2020
Diagnostic performance of <sup>18</sup> F-FDG-PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward
Elizabeth Hill, Esther Mena, Candis Morrison, et al.
JAMA Network Open
|
April 10, 2025
Long-Term Cancer Risk of US Service Members Exposed to Burn Pits in Iraq
Ian Robertson, Robert Sgrignoli, Alexander Dew, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 21, 2024
Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program
Alexander Dew, Jie Lin, Sarah Darmon, et al.
Blood Cancer Journal
|
May 7, 2026
MGUS prevalence among active-duty military personnel
Dickran Kazandjian, Christin DeStefano, Sarah Darmon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2008
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options
Alexander Dew, Demetria Collins, Andrew Artz, et al.
JAMA Oncology
|
November 19, 2020
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models
Elizabeth Hill, Alexander Dew, Candis Morrison, et al.
Clinical Trials (London, England)
|
January 17, 2013
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial
Alexander Dew, Seema Khan, Christie Babinski, et al.
Leukemia & Lymphoma
|
October 14, 2009
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence
Koen van Besien, Alexander Dew, Shang Lin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 15) with videos related to
Sort By:
Page
of 2
The New England Journal of Medicine
|
March 12, 2010
Stem-cell transplantation for sickle cell disease
Alexander Dew, Koen van Besien
Best Practice & Research. Clinical Haematology
|
March 7, 2020
The changing role of high dose melphalan with stem cell rescue in the treatment of newly diagnosed multiple myeloma in the era of modern therapies-back to the future!
Dickran Kazandjian, Alexander Dew, Elizabeth Hill
British Journal of Haematology
|
September 23, 2020
Diagnostic performance of <sup>18</sup> F-FDG-PET/CT compared to standard skeletal survey for detecting bone destruction in smouldering multiple myeloma: time to move forward
Elizabeth Hill, Esther Mena, Candis Morrison, et al.
JAMA Network Open
|
April 10, 2025
Long-Term Cancer Risk of US Service Members Exposed to Burn Pits in Iraq
Ian Robertson, Robert Sgrignoli, Alexander Dew, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
July 21, 2024
Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program
Alexander Dew, Jie Lin, Sarah Darmon, et al.
Blood Cancer Journal
|
May 7, 2026
MGUS prevalence among active-duty military personnel
Dickran Kazandjian, Christin DeStefano, Sarah Darmon, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 22, 2008
Paucity of HLA-identical unrelated donors for African-Americans with hematologic malignancies: the need for new donor options
Alexander Dew, Demetria Collins, Andrew Artz, et al.
JAMA Oncology
|
November 19, 2020
Assessment of Discordance Among Smoldering Multiple Myeloma Risk Models
Elizabeth Hill, Alexander Dew, Candis Morrison, et al.
Clinical Trials (London, England)
|
January 17, 2013
Recruitment strategy cost and impact on minority accrual to a breast cancer prevention trial
Alexander Dew, Seema Khan, Christie Babinski, et al.
Leukemia & Lymphoma
|
October 14, 2009
Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence
Koen van Besien, Alexander Dew, Shang Lin, et al.
Page
of 2